[1]
|
余孙兴, 黄慧雯, 谢艳艳, 等. 糖化血红蛋白联合空腹血糖在糖尿病和糖尿病前期筛查中的应用[J]. 糖尿病新世界, 2022, 25(19): 51-54+62. https://doi.org/10.16658/j.cnki.1672-4062.2022.19.051
|
[2]
|
赵芳, 张明霞, 武全莹. 从护理角度解读《2022年版中国老年2型糖尿病防治临床指南》[J]. 护理实践与研究, 2023, 20(9): 1263-1268.
|
[3]
|
陈奕任, 陈铭, 徐小惠, 陶人川, 梁韬. miR-124a对2型糖尿病小鼠胰腺组织氧化应激损伤的影响[J]. 中国药理学通报, 2023(8): 1493-1499.
|
[4]
|
付超, 张静, 董松武. 2型糖尿病病人脂代谢对心脏结构和功能的影响[J]. 安徽医药, 2021, 25(9): 1735-1738.
|
[5]
|
李慧歆, 邓立辉, 粟裕冬, 董波. 中药治疗糖尿病心肌病作用机制的研究进展[J]. 实用心脑肺血管病杂志, 2023, 31(7): 108-112.
|
[6]
|
戴婧, 郑丽, 王亚兰, 杨小师, 唐凤, 黎艳. 米诺环素调节AMPK/SIRT1/PGC-1α信号通路对糖尿病心肌病大鼠心肌损伤的影响[J]. 中国免疫学杂志, 2023: 1-15.
|
[7]
|
Ritchie, R.H. and Abel, E.D. (2020) Basic Mechanisms of Diabetic Heart Disease. Circulation Re-search, 126, 1501-1525. https://doi.org/10.1161/CIRCRESAHA.120.315913
|
[8]
|
刘玲, 李乃光, 管文娟. 沙库巴曲缬沙坦联合达格列净治疗糖尿病心肌病的疗效评价[J]. 中国合理用药探索, 2023, 20(6): 71-76.
|
[9]
|
李春锋, 姚鹏宇, 赵鑫, 徐彦, 高琛琛. 中药组分抗糖尿病心肌病作用机制研究进展[J]. 中医学报, 2023, 38(8): 1675-1685.
|
[10]
|
蔺洁, 雷烨, 李晓苗, 周洁. 小泛素化修饰调控糖尿病心肌病发生与发展[J]. 陕西医学杂志, 2023, 52(7): 929-933.
|
[11]
|
卢琳, 郭亚楠, 刘丽宏. 糖尿病心肌病发病机制的研究进展[J]. 中国冶金工业医学杂志, 2022, 39(2): 140-141.
|
[12]
|
宋小刚, 陈子仪, 马霞, 等. 脂毒性在糖尿病心肌病发病中作用的研究进展[J]. 中国病理生理杂志, 2022, 38(11): 2106-2112.
|
[13]
|
Azo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J.A. and Egido, J. (2020) Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic In-sights and Therapeutic Opportunities. International Journal of Molecular Sciences, 21, 2632. https://doi.org/10.3390/ijms21072632
|
[14]
|
Nakamura, M. and Sadoshima, J. (2020) Cardiomyopathy in Obesity, Insulin Resistance and Diabetes. The Journal of Physiology, 598, 2977-2993. https://doi.org/10.1113/JP276747
|
[15]
|
刘红霞, 戚本玲, 刘丽华. 脂毒性在糖尿病心肌病发病机制中的研究进展[J]. 临床心血管病杂志, 2020, 36(5): 406-409. https://doi.org/10.13201/j.issn.1001-1439.2020.05.003
|
[16]
|
Nakamura, K., Miyoshi, T., Yoshida, M., Akagi, S., Saito, Y., Ejiri, K., et al. (2022) Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus. International Journal of Molecular Sciences, 23, Article No. 3587. https://doi.org/10.3390/ijms23073587
|
[17]
|
Fillmore, N., Mori, J. and Lopaschuk, G.D. (2014) Mitochondrial Fatty Acid Oxidation Alterations in Heart Failure, Ischaemic Heart Disease and Diabetic Cardiomyopathy. British Journal of Pharmacology, 171, 2080-2090.
https://doi.org/10.1111/bph.12475
|
[18]
|
Shao, D., Kolwicz, S.C., Wang, P., Roe, N.D., Villet, O., Nishi, K., et al. (2020) Increasing Fatty Acid Oxidation Prevents High-Fat Diet-Induced Cardiomyopathy through Regulating Par-kin-Mediated Mitophagy. Circulation, 142, 983-997. https://doi.org/10.1161/CIRCULATIONAHA.119.043319
|
[19]
|
苏莎, 王蕾, 陆梓雯, 等. 从“心脾相关”理论探讨心力衰竭心脏能量代谢障碍[J]. 中西医结合心脑血管病杂志, 2023, 21(3): 562-566.
|
[20]
|
赵惠奇, 张青海, 郑昭芬. 从心肌能量代谢角度探讨射血分数保留的心力衰竭的治疗进展[J]. 实用心脑肺血管病杂志, 2023, 31(2): 1-7.
|
[21]
|
史小飞, 陈弋, 陈枫, 等. 改善心力衰竭能量代谢的潜在药物研究进展[J]. 药学实践与服务, 2023, 41(5): 284-290.
|
[22]
|
Chistiakov, D.A., Shkurat, T.P., Melnichenko, A.A., Grechko, A.V. and Orekhov, A.N. (2018) The Role of Mitochondrial Dysfunction in Cardiovascular Disease: A Brief Review. Annals of Medicine, 50, 121-127.
https://doi.org/10.1080/07853890.2017.1417631
|
[23]
|
Ma, X.M., Geng, K., Law, B.Y., Wang, P., Pu, Y.L., Chen, Q., Xu, H.W., Tan, X.Z., Jiang, Z.Z. and Xu, Y. (2023) Lipotoxicity-Induced mtDNA Release Promotes Diabetic Car-diomyopathy by Activating the cGAS-STING Pathway in Obesity-Related Diabetes. Cell Biology and Toxicology, 39, 277-299. https://doi.org/10.1007/s10565-021-09692-z
|
[24]
|
安冬, 梁永林, 赵思晨, 等. 脂毒性在2型糖尿病发生发展中作用的研究进展[J]. 中国糖尿病杂志, 2023, 31(1): 70-74.
|
[25]
|
郝一聪, 李强, 于萍. 脂毒性对胰岛素抵抗及胰岛β细胞功能的影响研究进展[J]. 中国医药, 2021, 16(8): 1258-1260.
|
[26]
|
Enito-Vicente, A., Jeba-ri-Benslaiman, S., Galicia-Garcia, U., Larrea-Sebal, A., Uribe, K.B. and Martin, C. (2021) Molecular Mechanisms of Lipotoxicity-Induced Pancreatic β-Cell Dysfunction. International Review of Cell and Molecular Biology, 359, 357-402. https://doi.org/10.1016/bs.ircmb.2021.02.013
|
[27]
|
Ahmed, B., Sultana, R. and Greene, M.W. (2021) Adipose Tis-sue and Insulin Resistance in Obese. Biomedicine & Pharmacotherapy, 137, Article ID: 111315. https://doi.org/10.1016/j.biopha.2021.111315
|
[28]
|
张娅, 张洁. 心肌胰岛素抵抗致心力衰竭研究进展[J]. 陕西医学杂志, 2023, 52(4): 495-497.
|
[29]
|
Aroor, A.R., Mandavia, C.H. and Sowers, J.R. (2012) Insulin Resistance and Heart Failure: Molecular Mechanisms. Heart Failure Clinics, 8, 609-617. https://doi.org/10.1016/j.hfc.2012.06.005
|
[30]
|
李莺莺. 生脉散通过氧化应激途径对糖尿病心肌病的改善作用及机制研究[D]: [硕士学位论文]. 济南: 山东中医药大学, 2022.
|
[31]
|
Incalza, M.A., D’Oria, R., Natalicchio, A., Perrini, S., Laviola, L. and Giorgino, F. (2018) Oxidative Stress and Reactive Oxygen Species in Endothelial Dysfunc-tion Associated with Cardiovascular and Metabolic Diseases. Vascular Pharmacology, 100, 1-19. https://doi.org/10.1016/j.vph.2017.05.005
|
[32]
|
郭俊凡, 张岳甫, 刘宇彤, 黄凤南, 周璐, 苏娃婷, 雷少青. 线粒体动力学失衡在糖尿病心肌缺血再灌注损伤中的作用[J]. 中华实用诊断与治疗杂志, 2022, 36(3): 317-320.
|
[33]
|
Chen, Z., Jin, Z.X., Cai, J., Li, R., Deng, K.Q., Ji, Y.X., Lei, F., Li, H.P., Lu, Z. and Li, H. (2022) Energy Substrate Metabolism and Oxidative Stress in Metabolic Cardiomyopathy. Journal of Molecular Medicine (Berlin), 100, 1721-1739. https://doi.org/10.1007/s00109-022-02269-1
|
[34]
|
Zhang, B., Li, X., Liu, G., Zhang, C., Zhang, X., Shen, Q., Sun, G. and Sun, X. (2021) Peroxiredomin-4 Ameliorates Lipotoxicity-Induced Oxidative Stress and Apopto-sis in Diabetic Cardiomyopathy. Biomedicine & Pharmacotherapy, 141, Article ID: 111780. https://doi.org/10.1016/j.biopha.2021.111780
|
[35]
|
Hauck, A.K. and Bernlohr, D.A. (2016) Oxidative Stress and Lipotoxicity. Journal of Lipid Research, 57, 1976-1986.
https://doi.org/10.1194/jlr.R066597
|
[36]
|
Mengstie, M.A., Abebe, E.C., Teklemariam, A.B., Mulu, A.T., Teshome, A.A., Zewde, E.A., Muche, Z.T. and Azezew, M.T. (2022) Molecular and Cellular Mechanisms in Diabetic Heart Failure: Potential Therapeutic Targets. Frontiers in Endocrinology (Lausanne), 13, Article ID: 947294. https://doi.org/10.3389/fendo.2022.947294
|